All three tested groups were characterized by downregulation of MMP13, a protein involved in the ECM breakdown, and upregulation of MYCL, which is associated with cancer susceptibility as well as metastasis, prognosis, and adverse survival. This evidence concerns the gene MYCL and cancer.